fashion -WSS

fashion

author：entertainment 2025-09-30 22:06:06 - browse：7

Stock illustration of computer and medication — Adobe

Digital therapeutics company Click Therapeutics announced Wednesday it will acquire the assets of Better Therapeutics, developer of a software-based treatment for diabetes. Click, which did not disclose how much it is paying for the assets, hopes to adapt Better’s tech for use alongside GLP-1 medications.

Better Therapeutics announced in March that it was delisting from the Nasdaq stock exchange and shutting down operations as it sought strategic alternatives. The company had been, since last year, searching for ways to stay afloat as its cash reserves dwindled.

Last, year, Better received Food and Drug Administration clearance for AspyreRx, a prescription app that delivers cognitive behavioral therapy and had been shown to reduce A1c levels in people with type 2 diabetes. Still, the company has been unable to ramp up significant commercial traction. Better also had a pipeline of other products targeting cardiometabolic conditions, and had made early claims about the benefits of AspyreRx in people taking GLP-1s for diabetes management.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Cancer drug shortages' outsize impact on ovarian cancer patients

WSS

Mississippi candidates for statewide offices square off in party primaries

Trump lawyer welcomes Pence testifying in Jan. 6 trial, won't say if Trump will too

Eye stem cell transplant could help restore vision in injured people

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

Trump Jan. 6 attorney John Lauro is ex

Clinical trials must include more disabled people

hotspot

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

Apple is now the first public company to be valued at $3 trillion

As Maui death toll rises, number of missing remains unclear

The cancer drug shortage isn’t new — and neither are the solutions

Biden will tout long

What does generative AI mean for health care? We asked experts

Why workplace violence is so common in health care

FDA approval of Sarepta Duchenne genetic therapy gives me hope

ActiGraph execs on goal of drug approvals with digital endpoints

New air purifier tech could be key to improving indoor air quality

Democratic lawmaker calls for 'well

hotspot

South Korea begins evacuating thousands of Scouts from coastal campsite as tropical storm nears

At least 12 people were injured in a blast at a port in northwest Turkey

Trump lawyer welcomes Pence testifying in Jan. 6 trial, won't say if Trump will too

Baltimore teen accused of firing into crowd during block party mass shooting

Trump cancels press conference intended to dispute Georgia election interference charges

Trump cancels press conference intended to dispute Georgia election interference charges

leisure time

explore

entertainment

focus